rs759385120

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_002435.3(MPI):​c.14G>C​(p.Arg5Pro) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000412 in 1,455,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R5L) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000041 ( 0 hom. )

Consequence

MPI
NM_002435.3 missense, splice_region

Scores

1
6
12
Splicing: ADA: 0.00005535
2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0330

Publications

2 publications found
Variant links:
Genes affected
MPI (HGNC:7216): (mannose phosphate isomerase) Phosphomannose isomerase catalyzes the interconversion of fructose-6-phosphate and mannose-6-phosphate and plays a critical role in maintaining the supply of D-mannose derivatives, which are required for most glycosylation reactions. Mutations in the MPI gene were found in patients with carbohydrate-deficient glycoprotein syndrome, type Ib. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
MPI Gene-Disease associations (from GenCC):
  • MPI-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, Myriad Women’s Health, G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.19278166).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MPINM_002435.3 linkc.14G>C p.Arg5Pro missense_variant, splice_region_variant Exon 1 of 8 ENST00000352410.9 NP_002426.1 P34949-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MPIENST00000352410.9 linkc.14G>C p.Arg5Pro missense_variant, splice_region_variant Exon 1 of 8 1 NM_002435.3 ENSP00000318318.6 P34949-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000412
AC:
6
AN:
1455834
Hom.:
0
Cov.:
31
AF XY:
0.00000276
AC XY:
2
AN XY:
724572
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33470
American (AMR)
AF:
0.00
AC:
0
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86240
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47650
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5662
European-Non Finnish (NFE)
AF:
0.00000540
AC:
6
AN:
1111940
Other (OTH)
AF:
0.00
AC:
0
AN:
60340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Pathogenic
0.25
D
BayesDel_noAF
Uncertain
0.12
CADD
Benign
14
DANN
Benign
0.69
DEOGEN2
Uncertain
0.52
D;T;.;.;T;T;.;.;.;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.11
N
LIST_S2
Uncertain
0.88
D;D;D;D;D;D;D;D;D;D
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.19
T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.069
T
MutationAssessor
Benign
0.030
N;.;.;.;.;.;.;N;.;.
PhyloP100
0.033
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-2.1
N;N;D;D;D;N;D;N;N;N
REVEL
Uncertain
0.58
Sift
Benign
0.077
T;T;T;T;T;T;D;T;T;T
Sift4G
Benign
0.21
T;T;T;T;T;T;T;T;T;T
Polyphen
0.0010
B;.;.;.;.;.;.;B;.;.
Vest4
0.54
MutPred
0.43
Gain of glycosylation at R5 (P = 0.0151);Gain of glycosylation at R5 (P = 0.0151);Gain of glycosylation at R5 (P = 0.0151);Gain of glycosylation at R5 (P = 0.0151);Gain of glycosylation at R5 (P = 0.0151);Gain of glycosylation at R5 (P = 0.0151);Gain of glycosylation at R5 (P = 0.0151);Gain of glycosylation at R5 (P = 0.0151);Gain of glycosylation at R5 (P = 0.0151);Gain of glycosylation at R5 (P = 0.0151);
MVP
0.58
MPC
0.27
ClinPred
0.076
T
GERP RS
-0.43
PromoterAI
-0.35
Neutral
Varity_R
0.34
gMVP
0.64
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000055
dbscSNV1_RF
Benign
0.010
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs759385120; hg19: chr15-75182428; COSMIC: COSV100086325; COSMIC: COSV100086325; API